• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡布特罗(SK&F 40383-A)的肾上腺素能活性特征

Characterization of the adrenergic activity of carbuterol (SK&F 40383-A).

作者信息

Colella D F, Chakrin L W, Shetzline A, Wardell J R

出版信息

Eur J Pharmacol. 1977 Dec 1;46(3):229-41. doi: 10.1016/0014-2999(77)90338-7.

DOI:10.1016/0014-2999(77)90338-7
PMID:22441
Abstract

Carbuterol is a beta-adrenergic bronchodilator with selectivity for bronchial smooth muscle relative to cardiac and vascular tissues of several species including man. The present studies were undertaken to further characterize its adrenergic profile. In vitro studies demonstrated that carbuterol was a direct acting beta-adrenergic agonist, not dependent on endogenous catecholamine release, and was devoid of alpha-adrenergic agonist activity. The activity of the racemate was shown to reside primarily in the l-enantiomer. Carbuterol inhibited immunologically induced release of histamine and slow reacting substance of anaphylaxis from passively sensitized fragmented rhesus monkey lung and also inhibited passive cutaneous anaphylaxis in rats. The relatively weak stimulant activity of carbuterol on beta1 receptors mediating both rate and force of contraction was confirmed in anesthetized open-chest dogs. In the anesthetized cat, carbuterol was significantly less potent than isoproterenol in decreasing diastolic blood pressure, increasing heart rate, and decreasing the tension and degree of fusion of incomplete tetanic contraction of the soleus muscle.

摘要

卡布特罗是一种β-肾上腺素能支气管扩张剂,相对于包括人类在内的几种物种的心脏和血管组织,它对支气管平滑肌具有选择性。目前的研究旨在进一步描述其肾上腺素能特征。体外研究表明,卡布特罗是一种直接作用的β-肾上腺素能激动剂,不依赖内源性儿茶酚胺释放,且无α-肾上腺素能激动剂活性。消旋体的活性主要存在于左旋对映体中。卡布特罗抑制免疫诱导的组胺释放以及被动致敏的恒河猴肺碎片中过敏反应迟缓反应物质的释放,并且还抑制大鼠的被动皮肤过敏反应。在麻醉的开胸犬中证实了卡布特罗对介导心率和收缩力的β1受体的刺激活性相对较弱。在麻醉的猫中,卡布特罗在降低舒张压、增加心率以及降低比目鱼肌不完全强直收缩的张力和融合程度方面的效力明显低于异丙肾上腺素。

相似文献

1
Characterization of the adrenergic activity of carbuterol (SK&F 40383-A).卡布特罗(SK&F 40383-A)的肾上腺素能活性特征
Eur J Pharmacol. 1977 Dec 1;46(3):229-41. doi: 10.1016/0014-2999(77)90338-7.
2
Studies on tetrahydroisoquinolines (THI). VI. Effects of trimetoquinol on tracheal and some other smooth muscles.四氢异喹啉(THI)的研究。VI. 曲美喹诺对气管及其他一些平滑肌的作用。
Arzneimittelforschung. 1970 Jan;20(1):46-52.
3
Adrenergic agents. 1. Synthesis and potential beta-adrenergic agonist activity of some catecholamine analogs bearing a substituted amino functionality in the meta position.
J Med Chem. 1974 Jan;17(1):49-57. doi: 10.1021/jm00247a011.
4
Species difference in the beta1/beta2-adrenoceptor selectivity of SM220CL in the cat and guinea-pig.SM220CL在猫和豚鼠体内β1/β2肾上腺素能受体选择性上的种属差异。
Clin Exp Pharmacol Physiol. 1977 Jul-Aug;4(4):349-58. doi: 10.1111/j.1440-1681.1977.tb02672.x.
5
Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.新型选择性β2激动剂马布特罗的药理学研究。II:对心血管系统和平滑肌器官的影响。
Arzneimittelforschung. 1984;34(11A):1641-51.
6
A study of the conformational requirements for direct adrenergic stimulation.一项关于直接肾上腺素能刺激的构象要求的研究。
J Med Chem. 1973 Sep;16(9):1023-7. doi: 10.1021/jm00267a014.
7
Quinterenol, a new beta adrenergic stimulant.喹特罗醇,一种新型β肾上腺素能兴奋剂。
J Pharmacol Exp Ther. 1968 Jul;162(1):60-9.
8
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.拉贝洛尔(一种α和β肾上腺素受体阻断联合药物)的动物药理学综述。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4.
9
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.AH 5158的药理学;一种能阻断α和β肾上腺素能受体的药物。
Br J Pharmacol. 1972 Aug;45(4):660-75. doi: 10.1111/j.1476-5381.1972.tb08125.x.
10
Vasodilation by medroxalol mediated by beta 2-adrenergic receptor stimulation.美多心安通过刺激β2-肾上腺素能受体介导血管舒张。
J Cardiovasc Pharmacol. 1983 Jan-Feb;5(1):143-50. doi: 10.1097/00005344-198301000-00022.

引用本文的文献

1
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.哮喘和 COPD:聚焦β-激动剂——过去、现在和未来。
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.